Table of Content

1 NASH Drug Pipeline Market Overview
1.1 NASH Drug Pipeline Product Overview
1.2 NASH Drug Pipeline Market Segment by Type
1.2.1 Protease Inhibitor
1.2.2 Immunomodulatory
1.2.3 Multiple Kinase Inhibitor
1.3 Global NASH Drug Pipeline Market Size by Type
1.3.1 Global NASH Drug Pipeline Market Size Overview by Type (2024-2034)
1.3.2 Global NASH Drug Pipeline Historic Market Size Review by Type (2024-2024)
1.3.3 Global NASH Drug Pipeline Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America NASH Drug Pipeline Sales Breakdown by Type (2024-2024)
1.4.2 Europe NASH Drug Pipeline Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific NASH Drug Pipeline Sales Breakdown by Type (2024-2024)
1.4.4 Latin America NASH Drug Pipeline Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa NASH Drug Pipeline Sales Breakdown by Type (2024-2024)
2 Global NASH Drug Pipeline Market Competition by Company
2.1 Global Top Players by NASH Drug Pipeline Sales (2024-2024)
2.2 Global Top Players by NASH Drug Pipeline Revenue (2024-2024)
2.3 Global Top Players by NASH Drug Pipeline Price (2024-2024)
2.4 Global Top Manufacturers NASH Drug Pipeline Manufacturing Base Distribution, Sales Area, Product Type
2.5 NASH Drug Pipeline Market Competitive Situation and Trends
2.5.1 NASH Drug Pipeline Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by NASH Drug Pipeline Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NASH Drug Pipeline as of 2022)
2.7 Date of Key Manufacturers Enter into NASH Drug Pipeline Market
2.8 Key Manufacturers NASH Drug Pipeline Product Offered
2.9 Mergers & Acquisitions, Expansion
3 NASH Drug Pipeline Status and Outlook by Region
3.1 Global NASH Drug Pipeline Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global NASH Drug Pipeline Historic Market Size by Region
3.2.1 Global NASH Drug Pipeline Sales in Volume by Region (2024-2024)
3.2.2 Global NASH Drug Pipeline Sales in Value by Region (2024-2024)
3.2.3 Global NASH Drug Pipeline Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global NASH Drug Pipeline Forecasted Market Size by Region
3.3.1 Global NASH Drug Pipeline Sales in Volume by Region (2024-2034)
3.3.2 Global NASH Drug Pipeline Sales in Value by Region (2024-2034)
3.3.3 Global NASH Drug Pipeline Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global NASH Drug Pipeline by Application
4.1 NASH Drug Pipeline Market Segment by Application
4.1.1 Clinical
4.1.2 Academic Research
4.2 Global NASH Drug Pipeline Market Size by Application
4.2.1 Global NASH Drug Pipeline Market Size Overview by Application (2024-2034)
4.2.2 Global NASH Drug Pipeline Historic Market Size Review by Application (2024-2024)
4.2.3 Global NASH Drug Pipeline Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America NASH Drug Pipeline Sales Breakdown by Application (2024-2024)
4.3.2 Europe NASH Drug Pipeline Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific NASH Drug Pipeline Sales Breakdown by Application (2024-2024)
4.3.4 Latin America NASH Drug Pipeline Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa NASH Drug Pipeline Sales Breakdown by Application (2024-2024)
5 North America NASH Drug Pipeline by Country
5.1 North America NASH Drug Pipeline Historic Market Size by Country
5.1.1 North America NASH Drug Pipeline Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America NASH Drug Pipeline Sales in Volume by Country (2024-2024)
5.1.3 North America NASH Drug Pipeline Sales in Value by Country (2024-2024)
5.2 North America NASH Drug Pipeline Forecasted Market Size by Country
5.2.1 North America NASH Drug Pipeline Sales in Volume by Country (2024-2034)
5.2.2 North America NASH Drug Pipeline Sales in Value by Country (2024-2034)
6 Europe NASH Drug Pipeline by Country
6.1 Europe NASH Drug Pipeline Historic Market Size by Country
6.1.1 Europe NASH Drug Pipeline Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe NASH Drug Pipeline Sales in Volume by Country (2024-2024)
6.1.3 Europe NASH Drug Pipeline Sales in Value by Country (2024-2024)
6.2 Europe NASH Drug Pipeline Forecasted Market Size by Country
6.2.1 Europe NASH Drug Pipeline Sales in Volume by Country (2024-2034)
6.2.2 Europe NASH Drug Pipeline Sales in Value by Country (2024-2034)
7 Asia-Pacific NASH Drug Pipeline by Region
7.1 Asia-Pacific NASH Drug Pipeline Historic Market Size by Region
7.1.1 Asia-Pacific NASH Drug Pipeline Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific NASH Drug Pipeline Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific NASH Drug Pipeline Sales in Value by Region (2024-2024)
7.2 Asia-Pacific NASH Drug Pipeline Forecasted Market Size by Region
7.2.1 Asia-Pacific NASH Drug Pipeline Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific NASH Drug Pipeline Sales in Value by Region (2024-2034)
8 Latin America NASH Drug Pipeline by Country
8.1 Latin America NASH Drug Pipeline Historic Market Size by Country
8.1.1 Latin America NASH Drug Pipeline Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America NASH Drug Pipeline Sales in Volume by Country (2024-2024)
8.1.3 Latin America NASH Drug Pipeline Sales in Value by Country (2024-2024)
8.2 Latin America NASH Drug Pipeline Forecasted Market Size by Country
8.2.1 Latin America NASH Drug Pipeline Sales in Volume by Country (2024-2034)
8.2.2 Latin America NASH Drug Pipeline Sales in Value by Country (2024-2034)
9 Middle East and Africa NASH Drug Pipeline by Country
9.1 Middle East and Africa NASH Drug Pipeline Historic Market Size by Country
9.1.1 Middle East and Africa NASH Drug Pipeline Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa NASH Drug Pipeline Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa NASH Drug Pipeline Sales in Value by Country (2024-2024)
9.2 Middle East and Africa NASH Drug Pipeline Forecasted Market Size by Country
9.2.1 Middle East and Africa NASH Drug Pipeline Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa NASH Drug Pipeline Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Intercept
10.1.1 Intercept Company Information
10.1.2 Intercept Introduction and Business Overview
10.1.3 Intercept NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Intercept NASH Drug Pipeline Products Offered
10.1.5 Intercept Recent Development
10.2 Genfit
10.2.1 Genfit Company Information
10.2.2 Genfit Introduction and Business Overview
10.2.3 Genfit NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Genfit NASH Drug Pipeline Products Offered
10.2.5 Genfit Recent Development
10.3 Allergan
10.3.1 Allergan Company Information
10.3.2 Allergan Introduction and Business Overview
10.3.3 Allergan NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Allergan NASH Drug Pipeline Products Offered
10.3.5 Allergan Recent Development
10.4 Madrigal
10.4.1 Madrigal Company Information
10.4.2 Madrigal Introduction and Business Overview
10.4.3 Madrigal NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Madrigal NASH Drug Pipeline Products Offered
10.4.5 Madrigal Recent Development
10.5 Immuron
10.5.1 Immuron Company Information
10.5.2 Immuron Introduction and Business Overview
10.5.3 Immuron NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Immuron NASH Drug Pipeline Products Offered
10.5.5 Immuron Recent Development
10.6 Galectin
10.6.1 Galectin Company Information
10.6.2 Galectin Introduction and Business Overview
10.6.3 Galectin NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Galectin NASH Drug Pipeline Products Offered
10.6.5 Galectin Recent Development
10.7 Gilead
10.7.1 Gilead Company Information
10.7.2 Gilead Introduction and Business Overview
10.7.3 Gilead NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Gilead NASH Drug Pipeline Products Offered
10.7.5 Gilead Recent Development
10.8 89bio Inc
10.8.1 89bio Inc Company Information
10.8.2 89bio Inc Introduction and Business Overview
10.8.3 89bio Inc NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.8.4 89bio Inc NASH Drug Pipeline Products Offered
10.8.5 89bio Inc Recent Development
10.9 ABIONYX Pharma SA
10.9.1 ABIONYX Pharma SA Company Information
10.9.2 ABIONYX Pharma SA Introduction and Business Overview
10.9.3 ABIONYX Pharma SA NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.9.4 ABIONYX Pharma SA NASH Drug Pipeline Products Offered
10.9.5 ABIONYX Pharma SA Recent Development
10.10 Abivax SA
10.10.1 Abivax SA Company Information
10.10.2 Abivax SA Introduction and Business Overview
10.10.3 Abivax SA NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Abivax SA NASH Drug Pipeline Products Offered
10.10.5 Abivax SA Recent Development
10.11 Abliva AB
10.11.1 Abliva AB Company Information
10.11.2 Abliva AB Introduction and Business Overview
10.11.3 Abliva AB NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Abliva AB NASH Drug Pipeline Products Offered
10.11.5 Abliva AB Recent Development
10.12 Acquist Therapeutics
10.12.1 Acquist Therapeutics Company Information
10.12.2 Acquist Therapeutics Introduction and Business Overview
10.12.3 Acquist Therapeutics NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Acquist Therapeutics NASH Drug Pipeline Products Offered
10.12.5 Acquist Therapeutics Recent Development
10.13 AdAlta Ltd
10.13.1 AdAlta Ltd Company Information
10.13.2 AdAlta Ltd Introduction and Business Overview
10.13.3 AdAlta Ltd NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.13.4 AdAlta Ltd NASH Drug Pipeline Products Offered
10.13.5 AdAlta Ltd Recent Development
10.14 Afimmune Biopharma Ltd
10.14.1 Afimmune Biopharma Ltd Company Information
10.14.2 Afimmune Biopharma Ltd Introduction and Business Overview
10.14.3 Afimmune Biopharma Ltd NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Afimmune Biopharma Ltd NASH Drug Pipeline Products Offered
10.14.5 Afimmune Biopharma Ltd Recent Development
10.15 Zhejiang Doer Biologics Corp
10.15.1 Zhejiang Doer Biologics Corp Company Information
10.15.2 Zhejiang Doer Biologics Corp Introduction and Business Overview
10.15.3 Zhejiang Doer Biologics Corp NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Zhejiang Doer Biologics Corp NASH Drug Pipeline Products Offered
10.15.5 Zhejiang Doer Biologics Corp Recent Development
10.16 Dicerna Pharmaceuticals Inc
10.16.1 Dicerna Pharmaceuticals Inc Company Information
10.16.2 Dicerna Pharmaceuticals Inc Introduction and Business Overview
10.16.3 Dicerna Pharmaceuticals Inc NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Dicerna Pharmaceuticals Inc NASH Drug Pipeline Products Offered
10.16.5 Dicerna Pharmaceuticals Inc Recent Development
10.17 ChemomAb Ltd
10.17.1 ChemomAb Ltd Company Information
10.17.2 ChemomAb Ltd Introduction and Business Overview
10.17.3 ChemomAb Ltd NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.17.4 ChemomAb Ltd NASH Drug Pipeline Products Offered
10.17.5 ChemomAb Ltd Recent Development
10.18 DURECT Corp
10.18.1 DURECT Corp Company Information
10.18.2 DURECT Corp Introduction and Business Overview
10.18.3 DURECT Corp NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.18.4 DURECT Corp NASH Drug Pipeline Products Offered
10.18.5 DURECT Corp Recent Development
10.19 Eli Lilly and Co
10.19.1 Eli Lilly and Co Company Information
10.19.2 Eli Lilly and Co Introduction and Business Overview
10.19.3 Eli Lilly and Co NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Eli Lilly and Co NASH Drug Pipeline Products Offered
10.19.5 Eli Lilly and Co Recent Development
10.20 Enanta Pharmaceuticals Inc
10.20.1 Enanta Pharmaceuticals Inc Company Information
10.20.2 Enanta Pharmaceuticals Inc Introduction and Business Overview
10.20.3 Enanta Pharmaceuticals Inc NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.20.4 Enanta Pharmaceuticals Inc NASH Drug Pipeline Products Offered
10.20.5 Enanta Pharmaceuticals Inc Recent Development
10.21 EncuraGen Inc
10.21.1 EncuraGen Inc Company Information
10.21.2 EncuraGen Inc Introduction and Business Overview
10.21.3 EncuraGen Inc NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.21.4 EncuraGen Inc NASH Drug Pipeline Products Offered
10.21.5 EncuraGen Inc Recent Development
10.22 Engitix Ltd
10.22.1 Engitix Ltd Company Information
10.22.2 Engitix Ltd Introduction and Business Overview
10.22.3 Engitix Ltd NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.22.4 Engitix Ltd NASH Drug Pipeline Products Offered
10.22.5 Engitix Ltd Recent Development
10.23 Heprotech Inc
10.23.1 Heprotech Inc Company Information
10.23.2 Heprotech Inc Introduction and Business Overview
10.23.3 Heprotech Inc NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.23.4 Heprotech Inc NASH Drug Pipeline Products Offered
10.23.5 Heprotech Inc Recent Development
10.24 Hinova Pharmaceuticals Inc
10.24.1 Hinova Pharmaceuticals Inc Company Information
10.24.2 Hinova Pharmaceuticals Inc Introduction and Business Overview
10.24.3 Hinova Pharmaceuticals Inc NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.24.4 Hinova Pharmaceuticals Inc NASH Drug Pipeline Products Offered
10.24.5 Hinova Pharmaceuticals Inc Recent Development
10.25 HK inno.N Corp
10.25.1 HK inno.N Corp Company Information
10.25.2 HK inno.N Corp Introduction and Business Overview
10.25.3 HK inno.N Corp NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.25.4 HK inno.N Corp NASH Drug Pipeline Products Offered
10.25.5 HK inno.N Corp Recent Development
10.26 HotSpot Therapeutics Inc
10.26.1 HotSpot Therapeutics Inc Company Information
10.26.2 HotSpot Therapeutics Inc Introduction and Business Overview
10.26.3 HotSpot Therapeutics Inc NASH Drug Pipeline Sales, Revenue and Gross Margin (2024-2024)
10.26.4 HotSpot Therapeutics Inc NASH Drug Pipeline Products Offered
10.26.5 HotSpot Therapeutics Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 NASH Drug Pipeline Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 NASH Drug Pipeline Industrial Chain Analysis
11.4 NASH Drug Pipeline Market Dynamics
11.4.1 NASH Drug Pipeline Industry Trends
11.4.2 NASH Drug Pipeline Market Drivers
11.4.3 NASH Drug Pipeline Market Challenges
11.4.4 NASH Drug Pipeline Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 NASH Drug Pipeline Distributors
12.3 NASH Drug Pipeline Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Protease Inhibitor
Table 2. Major Company of Immunomodulatory
Table 3. Major Company of Multiple Kinase Inhibitor
Table 4. Global NASH Drug Pipeline Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global NASH Drug Pipeline Sales by Type (2024-2024) & (K Units)
Table 6. Global NASH Drug Pipeline Sales Market Share in Volume by Type (2024-2024)
Table 7. Global NASH Drug Pipeline Sales by Type (2024-2024) & (US& Million)
Table 8. Global NASH Drug Pipeline Market Share in Value by Type (2024-2024)
Table 9. Global NASH Drug Pipeline Price by Type (2024-2024) & (US$/Unit)
Table 10. Global NASH Drug Pipeline Sales by Type (2024-2034) & (K Units)
Table 11. Global NASH Drug Pipeline Sales Market Share in Volume by Type (2024-2034)
Table 12. Global NASH Drug Pipeline Sales by Type (2024-2034) & (US$ Million)
Table 13. Global NASH Drug Pipeline Sales Market Share in Value by Type (2024-2034)
Table 14. Global NASH Drug Pipeline Price by Type (2024-2034) & (US$/Unit)
Table 15. North America NASH Drug Pipeline Sales by Type (2024-2024) & (K Units)
Table 16. North America NASH Drug Pipeline Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe NASH Drug Pipeline Sales (K Units) by Type (2024-2024)
Table 18. Europe NASH Drug Pipeline Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific NASH Drug Pipeline Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific NASH Drug Pipeline Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America NASH Drug Pipeline Sales (K Units) by Type (2024-2024)
Table 22. Latin America NASH Drug Pipeline Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa NASH Drug Pipeline Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa NASH Drug Pipeline Sales by Type (2024-2024) & (US$ Million)
Table 25. Global NASH Drug Pipeline Sales by Company (2024-2024) & (K Units)
Table 26. Global NASH Drug Pipeline Sales Share by Company (2024-2024)
Table 27. Global NASH Drug Pipeline Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global NASH Drug Pipeline Revenue Share by Company (2024-2024)
Table 29. Global Market NASH Drug Pipeline Price by Company (2024-2024) & (US$/Unit)
Table 30. Global NASH Drug Pipeline Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global NASH Drug Pipeline Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NASH Drug Pipeline as of 2022)
Table 33. Date of Key Manufacturers Enter into NASH Drug Pipeline Market
Table 34. Key Manufacturers NASH Drug Pipeline Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global NASH Drug Pipeline Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global NASH Drug Pipeline Sales by Region (2024-2024) & (K Units)
Table 38. Global NASH Drug Pipeline Sales Market Share in Volume by Region (2024-2024)
Table 39. Global NASH Drug Pipeline Sales by Region (2024-2024) & (US$ Million)
Table 40. Global NASH Drug Pipeline Sales Market Share in Value by Region (2024-2024)
Table 41. Global NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 42. Global NASH Drug Pipeline Sales by Region (2024-2034) & (K Units)
Table 43. Global NASH Drug Pipeline Sales Market Share in Volume by Region (2024-2034)
Table 44. Global NASH Drug Pipeline Sales by Region (2024-2034) & (US$ Million)
Table 45. Global NASH Drug Pipeline Sales Market Share in Value by Region (2024-2034)
Table 46. Global NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global NASH Drug Pipeline Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global NASH Drug Pipeline Sales by Application (2024-2024) & (K Units)
Table 49. Global NASH Drug Pipeline Sales Market Share in Volume by Application (2024-2024)
Table 50. Global NASH Drug Pipeline Sales by Application (2024-2024) & (US$ Million)
Table 51. Global NASH Drug Pipeline Sales Market Share in Value by Application (2024-2024)
Table 52. Global NASH Drug Pipeline Price by Application (2024-2024) & (US$/Unit)
Table 53. Global NASH Drug Pipeline Sales by Application (2024-2034) & (K Units)
Table 54. Global NASH Drug Pipeline Sales Market Share in Volume by Application (2024-2034)
Table 55. Global NASH Drug Pipeline Sales by Application (2024-2034) & (US$ Million)
Table 56. Global NASH Drug Pipeline Sales Market Share in Value by Application (2024-2034)
Table 57. Global NASH Drug Pipeline Price by Application (2024-2034) & (US$/Unit)
Table 58. North America NASH Drug Pipeline Sales by Application (2024-2024) (K Units)
Table 59. North America NASH Drug Pipeline Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe NASH Drug Pipeline Sales by Application (2024-2024) (K Units)
Table 61. Europe NASH Drug Pipeline Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific NASH Drug Pipeline Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific NASH Drug Pipeline Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America NASH Drug Pipeline Sales by Application (2024-2024) (K Units)
Table 65. Latin America NASH Drug Pipeline Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa NASH Drug Pipeline Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa NASH Drug Pipeline Sales by Application (2024-2024) & (US$ Million)
Table 68. North America NASH Drug Pipeline Sales by Country (2024-2024) & (K Units)
Table 69. North America NASH Drug Pipeline Sales Market Share in Volume by Country (2024-2024)
Table 70. North America NASH Drug Pipeline Sales by Country (2024-2024) & (US$ Million)
Table 71. North America NASH Drug Pipeline Sales Market Share in Value by Country (2024-2024)
Table 72. North America NASH Drug Pipeline Sales by Country (2024-2034) & (K Units)
Table 73. North America NASH Drug Pipeline Sales Market Share in Volume by Country (2024-2034)
Table 74. North America NASH Drug Pipeline Sales by Country (2024-2034) & (US$ Million)
Table 75. North America NASH Drug Pipeline Sales Market Share in Value by Country (2024-2034)
Table 76. Europe NASH Drug Pipeline Sales by Country (2024-2024) & (K Units)
Table 77. Europe NASH Drug Pipeline Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe NASH Drug Pipeline Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe NASH Drug Pipeline Sales Market Share in Value by Country (2024-2024)
Table 80. Europe NASH Drug Pipeline Sales by Country (2024-2034) & (K Units)
Table 81. Europe NASH Drug Pipeline Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe NASH Drug Pipeline Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe NASH Drug Pipeline Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific NASH Drug Pipeline Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific NASH Drug Pipeline Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific NASH Drug Pipeline Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific NASH Drug Pipeline Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific NASH Drug Pipeline Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific NASH Drug Pipeline Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific NASH Drug Pipeline Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific NASH Drug Pipeline Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America NASH Drug Pipeline Sales by Country (2024-2024) & (K Units)
Table 93. Latin America NASH Drug Pipeline Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America NASH Drug Pipeline Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America NASH Drug Pipeline Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America NASH Drug Pipeline Sales by Country (2024-2034) & (K Units)
Table 97. Latin America NASH Drug Pipeline Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America NASH Drug Pipeline Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America NASH Drug Pipeline Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa NASH Drug Pipeline Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa NASH Drug Pipeline Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa NASH Drug Pipeline Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa NASH Drug Pipeline Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa NASH Drug Pipeline Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa NASH Drug Pipeline Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa NASH Drug Pipeline Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa NASH Drug Pipeline Sales Market Share in Value by Country (2024-2034)
Table 108. Intercept Company Information
Table 109. Intercept Introduction and Business Overview
Table 110. Intercept NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 111. Intercept NASH Drug Pipeline Product
Table 112. Intercept Recent Development
Table 113. Genfit Company Information
Table 114. Genfit Introduction and Business Overview
Table 115. Genfit NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 116. Genfit NASH Drug Pipeline Product
Table 117. Genfit Recent Development
Table 118. Allergan Company Information
Table 119. Allergan Introduction and Business Overview
Table 120. Allergan NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 121. Allergan NASH Drug Pipeline Product
Table 122. Allergan Recent Development
Table 123. Madrigal Company Information
Table 124. Madrigal Introduction and Business Overview
Table 125. Madrigal NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 126. Madrigal NASH Drug Pipeline Product
Table 127. Madrigal Recent Development
Table 128. Immuron Company Information
Table 129. Immuron Introduction and Business Overview
Table 130. Immuron NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 131. Immuron NASH Drug Pipeline Product
Table 132. Immuron Recent Development
Table 133. Galectin Company Information
Table 134. Galectin Introduction and Business Overview
Table 135. Galectin NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 136. Galectin NASH Drug Pipeline Product
Table 137. Galectin Recent Development
Table 138. Gilead Company Information
Table 139. Gilead Introduction and Business Overview
Table 140. Gilead NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 141. Gilead NASH Drug Pipeline Product
Table 142. Gilead Recent Development
Table 143. 89bio Inc Company Information
Table 144. 89bio Inc Introduction and Business Overview
Table 145. 89bio Inc NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 146. 89bio Inc NASH Drug Pipeline Product
Table 147. 89bio Inc Recent Development
Table 148. ABIONYX Pharma SA Company Information
Table 149. ABIONYX Pharma SA Introduction and Business Overview
Table 150. ABIONYX Pharma SA NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 151. ABIONYX Pharma SA NASH Drug Pipeline Product
Table 152. ABIONYX Pharma SA Recent Development
Table 153. Abivax SA Company Information
Table 154. Abivax SA Introduction and Business Overview
Table 155. Abivax SA NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 156. Abivax SA NASH Drug Pipeline Product
Table 157. Abivax SA Recent Development
Table 158. Abliva AB Company Information
Table 159. Abliva AB Introduction and Business Overview
Table 160. Abliva AB NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 161. Abliva AB NASH Drug Pipeline Product
Table 162. Abliva AB Recent Development
Table 163. Acquist Therapeutics Company Information
Table 164. Acquist Therapeutics Introduction and Business Overview
Table 165. Acquist Therapeutics NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 166. Acquist Therapeutics NASH Drug Pipeline Product
Table 167. Acquist Therapeutics Recent Development
Table 168. AdAlta Ltd Company Information
Table 169. AdAlta Ltd Introduction and Business Overview
Table 170. AdAlta Ltd NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 171. AdAlta Ltd NASH Drug Pipeline Product
Table 172. AdAlta Ltd Recent Development
Table 173. Afimmune Biopharma Ltd Company Information
Table 174. Afimmune Biopharma Ltd Introduction and Business Overview
Table 175. Afimmune Biopharma Ltd NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 176. Afimmune Biopharma Ltd NASH Drug Pipeline Product
Table 177. Afimmune Biopharma Ltd Recent Development
Table 178. Zhejiang Doer Biologics Corp Company Information
Table 179. Zhejiang Doer Biologics Corp Introduction and Business Overview
Table 180. Zhejiang Doer Biologics Corp NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 181. Zhejiang Doer Biologics Corp NASH Drug Pipeline Product
Table 182. Zhejiang Doer Biologics Corp Recent Development
Table 183. Dicerna Pharmaceuticals Inc Company Information
Table 184. Dicerna Pharmaceuticals Inc Introduction and Business Overview
Table 185. Dicerna Pharmaceuticals Inc NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 186. Dicerna Pharmaceuticals Inc NASH Drug Pipeline Product
Table 187. Dicerna Pharmaceuticals Inc Recent Development
Table 188. ChemomAb Ltd Company Information
Table 189. ChemomAb Ltd Introduction and Business Overview
Table 190. ChemomAb Ltd NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 191. ChemomAb Ltd NASH Drug Pipeline Product
Table 192. ChemomAb Ltd Recent Development
Table 193. DURECT Corp Company Information
Table 194. DURECT Corp Introduction and Business Overview
Table 195. DURECT Corp NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 196. DURECT Corp NASH Drug Pipeline Product
Table 197. DURECT Corp Recent Development
Table 198. Eli Lilly and Co Company Information
Table 199. Eli Lilly and Co Introduction and Business Overview
Table 200. Eli Lilly and Co NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 201. Eli Lilly and Co NASH Drug Pipeline Product
Table 202. Eli Lilly and Co Recent Development
Table 203. Enanta Pharmaceuticals Inc Company Information
Table 204. Enanta Pharmaceuticals Inc Introduction and Business Overview
Table 205. Enanta Pharmaceuticals Inc NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 206. Enanta Pharmaceuticals Inc NASH Drug Pipeline Product
Table 207. Enanta Pharmaceuticals Inc Recent Development
Table 208. EncuraGen Inc Company Information
Table 209. EncuraGen Inc Introduction and Business Overview
Table 210. EncuraGen Inc NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 211. EncuraGen Inc NASH Drug Pipeline Product
Table 212. EncuraGen Inc Recent Development
Table 213. Engitix Ltd Company Information
Table 214. Engitix Ltd Introduction and Business Overview
Table 215. Engitix Ltd NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 216. Engitix Ltd NASH Drug Pipeline Product
Table 217. Engitix Ltd Recent Development
Table 218. Heprotech Inc Company Information
Table 219. Heprotech Inc Introduction and Business Overview
Table 220. Heprotech Inc NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 221. Heprotech Inc NASH Drug Pipeline Product
Table 222. Heprotech Inc Recent Development
Table 223. Hinova Pharmaceuticals Inc Company Information
Table 224. Hinova Pharmaceuticals Inc Introduction and Business Overview
Table 225. Hinova Pharmaceuticals Inc NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 226. Hinova Pharmaceuticals Inc NASH Drug Pipeline Product
Table 227. Hinova Pharmaceuticals Inc Recent Development
Table 228. HK inno.N Corp Introduction and Business Overview
Table 229. HK inno.N Corp NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 230. HK inno.N Corp NASH Drug Pipeline Product
Table 231. HK inno.N Corp Recent Development
Table 232. HK inno.N Corp Company Information
Table 233. HotSpot Therapeutics Inc Company Information
Table 234. HotSpot Therapeutics Inc Introduction and Business Overview
Table 235. HotSpot Therapeutics Inc NASH Drug Pipeline Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 236. HotSpot Therapeutics Inc NASH Drug Pipeline Product
Table 237. HotSpot Therapeutics Inc Recent Development
Table 238. Key Raw Materials Lists
Table 239. Raw Materials Key Suppliers Lists
Table 240. NASH Drug Pipeline Market Trends
Table 241. NASH Drug Pipeline Market Drivers
Table 242. NASH Drug Pipeline Market Challenges
Table 243. NASH Drug Pipeline Market Restraints
Table 244. NASH Drug Pipeline Distributors List
Table 245. NASH Drug Pipeline Downstream Customers
Table 246. Research Programs/Design for This Report
Table 247. Key Data Information from Secondary Sources
Table 248. Key Data Information from Primary Sources
List of Figures
Figure 1. NASH Drug Pipeline Product Picture
Figure 2. Global NASH Drug Pipeline Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global NASH Drug Pipeline Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global NASH Drug Pipeline Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Protease Inhibitor
Figure 6. Global By Mechanism of Action Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Immunomodulatory
Figure 8. Global By Molecule Types Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Multiple Kinase Inhibitor
Figure 10. Global Multiple Kinase Inhibitor Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global NASH Drug Pipeline Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global NASH Drug Pipeline Sales Market Share by Type in 2022 & 2034
Figure 13. North America NASH Drug Pipeline Sales Market Share in Volume by Type in 2022
Figure 14. North America NASH Drug Pipeline Sales Market Share in Value by Type in 2022
Figure 15. Europe NASH Drug Pipeline Sales Market Share in Volume by Type in 2022
Figure 16. Europe NASH Drug Pipeline Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific NASH Drug Pipeline Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific NASH Drug Pipeline Sales Market Share in Value by Type in 2022
Figure 19. Latin America NASH Drug Pipeline Sales Market Share in Volume by Type in 2022
Figure 20. Latin America NASH Drug Pipeline Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa NASH Drug Pipeline Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa NASH Drug Pipeline Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by NASH Drug Pipeline Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by NASH Drug Pipeline Revenue in 2022
Figure 25. NASH Drug Pipeline Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Clinical
Figure 27. Global Clinical Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Academic Research
Figure 29. Global Academic Research Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global NASH Drug Pipeline Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global NASH Drug Pipeline Sales Market Share by Application in 2022 & 2034
Figure 32. North America NASH Drug Pipeline Sales Market Share in Volume by Application in 2022
Figure 33. North America NASH Drug Pipeline Sales Market Share in Value by Application in 2022
Figure 34. Europe NASH Drug Pipeline Sales Market Share in Volume by Application in 2022
Figure 35. Europe NASH Drug Pipeline Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific NASH Drug Pipeline Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific NASH Drug Pipeline Sales Market Share in Value by Application in 2022
Figure 38. Latin America NASH Drug Pipeline Sales Market Share in Volume by Application in 2022
Figure 39. Latin America NASH Drug Pipeline Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa NASH Drug Pipeline Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. NASH Drug Pipeline Manufacturing Cost Structure
Figure 43. NASH Drug Pipeline Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed